168 related articles for article (PubMed ID: 38359985)
41. Selective inhibition of APOBEC3 enzymes by single-stranded DNAs containing 2'-deoxyzebularine.
Barzak FM; Harjes S; Kvach MV; Kurup HM; Jameson GB; Filichev VV; Harjes E
Org Biomol Chem; 2019 Nov; 17(43):9435-9441. PubMed ID: 31603457
[TBL] [Abstract][Full Text] [Related]
42. Action-at-a-distance mutations induced by 8-oxo-7,8-dihydroguanine are dependent on APOBEC3.
Fukushima R; Suzuki T; Kobayakawa A; Kamiya H
Mutagenesis; 2024 Feb; 39(1):24-31. PubMed ID: 37471265
[TBL] [Abstract][Full Text] [Related]
43. Small-Angle X-ray Scattering (SAXS) Measurements of APOBEC3G Provide Structural Basis for Binding of Single-Stranded DNA and Processivity.
Barzak FM; Ryan TM; Mohammadzadeh N; Harjes S; Kvach MV; Kurup HM; Krause KL; Chelico L; Filichev VV; Harjes E; Jameson GB
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146779
[TBL] [Abstract][Full Text] [Related]
44. Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses.
Verhalen B; Starrett GJ; Harris RS; Jiang M
J Virol; 2016 Jul; 90(14):6379-6386. PubMed ID: 27147740
[TBL] [Abstract][Full Text] [Related]
45. An extended APOBEC3A mutation signature in cancer.
Langenbucher A; Bowen D; Sakhtemani R; Bournique E; Wise JF; Zou L; Bhagwat AS; Buisson R; Lawrence MS
Nat Commun; 2021 Mar; 12(1):1602. PubMed ID: 33707442
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteins.
Wiegand HL; Cullen BR
J Virol; 2007 Dec; 81(24):13694-9. PubMed ID: 17913830
[TBL] [Abstract][Full Text] [Related]
47. Mitochondrial double-stranded RNA triggers induction of the antiviral DNA deaminase APOBEC3A and nuclear DNA damage.
Wick C; Moghadasi SA; Becker JT; Fanunza E; Oh S; Bournique E; Buisson R; Harris RS
J Biol Chem; 2023 Sep; 299(9):105073. PubMed ID: 37474103
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penis.
Trimmel B; Oszwald A; Diemand C; Ertl IE; Lemberger U; Bruchbacher A; Brettner R; Korn S; Resch I; Comperat E; Shariat SF; Hassler MR
Sci Rep; 2022 Jul; 12(1):12911. PubMed ID: 35902635
[TBL] [Abstract][Full Text] [Related]
49. Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation.
Westrich JA; Warren CJ; Klausner MJ; Guo K; Liu CW; Santiago ML; Pyeon D
J Virol; 2018 Apr; 92(7):. PubMed ID: 29367246
[TBL] [Abstract][Full Text] [Related]
50. Inhibiting APOBEC3 Activity with Single-Stranded DNA Containing 2'-Deoxyzebularine Analogues.
Kvach MV; Barzak FM; Harjes S; Schares HAM; Jameson GB; Ayoub AM; Moorthy R; Aihara H; Harris RS; Filichev VV; Harki DA; Harjes E
Biochemistry; 2019 Feb; 58(5):391-400. PubMed ID: 30418757
[TBL] [Abstract][Full Text] [Related]
51. APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism.
Chen TW; Lee CC; Liu H; Wu CS; Pickering CR; Huang PJ; Wang J; Chang IY; Yeh YM; Chen CD; Li HP; Luo JD; Tan BC; Chan TEH; Hsueh C; Chu LJ; Chen YT; Zhang B; Yang CY; Wu CC; Hsu CW; See LC; Tang P; Yu JS; Liao WC; Chiang WF; Rodriguez H; Myers JN; Chang KP; Chang YS
Nat Commun; 2017 Sep; 8(1):465. PubMed ID: 28878238
[TBL] [Abstract][Full Text] [Related]
52. APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer.
McCann JL; Cristini A; Law EK; Lee SY; Tellier M; Carpenter MA; Beghè C; Kim JJ; Sanchez A; Jarvis MC; Stefanovska B; Temiz NA; Bergstrom EN; Salamango DJ; Brown MR; Murphy S; Alexandrov LB; Miller KM; Gromak N; Harris RS
Nat Genet; 2023 Oct; 55(10):1721-1734. PubMed ID: 37735199
[TBL] [Abstract][Full Text] [Related]
53. Clinical implications of APOBEC3A and 3B expression in patients with breast cancer.
Kim YS; Sun S; Yoon JS; Ko YH; Won HS; Kim JS
PLoS One; 2020; 15(3):e0230261. PubMed ID: 32176735
[TBL] [Abstract][Full Text] [Related]
54. APOBEC3A/B deletion polymorphism and cancer risk.
Gansmo LB; Romundstad P; Hveem K; Vatten L; Nik-Zainal S; Lønning PE; Knappskog S
Carcinogenesis; 2018 Feb; 39(2):118-124. PubMed ID: 29140415
[TBL] [Abstract][Full Text] [Related]
55. A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage.
Caval V; Suspène R; Shapira M; Vartanian JP; Wain-Hobson S
Nat Commun; 2014 Oct; 5():5129. PubMed ID: 25298230
[TBL] [Abstract][Full Text] [Related]
56. Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B.
Shi K; Carpenter MA; Banerjee S; Shaban NM; Kurahashi K; Salamango DJ; McCann JL; Starrett GJ; Duffy JV; Demir Ö; Amaro RE; Harki DA; Harris RS; Aihara H
Nat Struct Mol Biol; 2017 Feb; 24(2):131-139. PubMed ID: 27991903
[TBL] [Abstract][Full Text] [Related]
57. Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population.
Göhler S; Da Silva Filho MI; Johansson R; Enquist-Olsson K; Henriksson R; Hemminki K; Lenner P; Försti A
J Cancer Res Clin Oncol; 2016 Jan; 142(1):273-6. PubMed ID: 26320772
[TBL] [Abstract][Full Text] [Related]
58. Conservation and Innovation of APOBEC3A Restriction Functions during Primate Evolution.
McLaughlin RN; Gable JT; Wittkopp CJ; Emerman M; Malik HS
Mol Biol Evol; 2016 Aug; 33(8):1889-901. PubMed ID: 27189538
[TBL] [Abstract][Full Text] [Related]
59. APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion.
Nowarski R; Kotler M
Cancer Res; 2013 Jun; 73(12):3494-8. PubMed ID: 23598277
[TBL] [Abstract][Full Text] [Related]
60. Protein kinase A inhibits tumor mutator APOBEC3B through phosphorylation.
Matsumoto T; Shirakawa K; Yokoyama M; Fukuda H; Sarca AD; Koyabu S; Yamazaki H; Kazuma Y; Matsui H; Maruyama W; Nagata K; Tanabe F; Kobayashi M; Shindo K; Morishita R; Sato H; Takaori-Kondo A
Sci Rep; 2019 Jun; 9(1):8307. PubMed ID: 31165764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
